Stay updated with breaking news from Jonathan Pappas. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
BOSTON, April 24, 2024 -- Cue Biopharma, Inc. , a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively modulate disease-specific T cells,...
BOSTON, April 08, 2024 -- Cue Biopharma, Inc. , a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively modulate disease-specific T cells, today...
BOSTON, April 02, 2024 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively modulate disease-specific T cells, announced
BOSTON, April 02, 2024 -- Cue Biopharma, Inc. , a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively modulate disease-specific T cells,...
POLITICO Get the Massachusetts Playbook newsletter Email Sign Up By signing up you agree to receive email newsletters or updates from POLITICO and you agree to our privacy policy and terms of service. You can unsubscribe at any time and you can contact us here. This sign-up form is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. Presented by Uber Driver Stories GOOD MORNING, MASSACHUSETTS. NEW: ANTI-HAWLEY PAC LAUNCHES IN MASS. — A new Massachusetts-based PAC has its eye on an ambitious U.S. Senator from Missouri. The U Against Hawley PAC,launched by alumni...